Article thumbnail

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial

By Gerald Fogarty, Rachael L Morton, Janette Vardy, Anna K Nowak, Catherine Mandel, Peta M Forder, Angela Hong, George Hruby, Bryan Burmeister, Brindha Shivalingam, Haryana Dhillon and John F Thompson
Topics: Study Protocol
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1983). Clinical trials: a practical approach.
  2. (2004). Cognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
  3. (1993). de Haes JC, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a qualityof-life instrument for use in international clinical trials in oncology.
  4. (2011). et al: Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study.
  5. (2009). et al: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncology
  6. (2006). et al: Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases.
  7. (2004). Gogas H: The treatment of brain metastases in melanoma patients. Cancer Treat Rev
  8. (1998). HF: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.
  9. (1992). Management of brain metastases. Revue Neurologique
  10. (1996). Newlands E: The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res
  11. (1998). Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA
  12. (2004). Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiotherapy and Oncology
  13. (2003). Wefel JS: The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.
  14. (2000). WH: Neurocognitive effects of therapeutic irradiation for base of skull tumors.
  15. (2006). Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiotherapy and Oncology
  16. (2010). Whole-brain irradiation for patients with brain metastases: still the standard of care. Lancet Oncology